-
Product Insights
NewGrowth Hormone Deficiency – Drugs In Development, 2024
Empower your strategies with our Growth Hormone Deficiency – Drugs In Development, 2024 report and make more profitable business decisions. Growth hormone deficiency (GHD) is a rare and treatable condition that occurs when the pituitary gland does not produce enough growth hormone (GH). GH is a hormone that stimulates growth and metabolism in the body. GHD can affect children and adults, but it has different effects depending on the age of onset. Children with GHD have short stature, delayed puberty, low...
-
Product Insights
NewPrader-Willi Syndrome (PWS) – Drugs In Development, 2024
Empower your strategies with our Prader-Willi Syndrome (PWS) – Drugs In Development, 2024 report and make more profitable business decisions. Prader-Willi syndrome (PWS) is a rare congenital genetic disorder that results in a number of physical, mental, and behavioral problems. PWS is due to the lack of several genes on one of an individual’s two chromosome 15s. In the majority of cases, there is a deletion. In the remaining cases, the entire chromosome from the father is missing and there are...
-
Product Insights
NewEndocrine Gland Disorders – Drugs In Development, 2024
Empower your strategies with our Endocrine Gland Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Endocrine gland disorders are medical conditions that affect the function of the endocrine system, which is a network of glands that produce and release hormones that regulate many body processes. Some common endocrine disorders are diabetes, hyperthyroidism, hypothyroidism, Cushing's disease, and polycystic ovary syndrome (PCOS). These disorders can result from various causes, such as tumors, genetic factors, hormonal imbalances, or autoimmune...
-
Product Insights
NewPediatric Diffuse Intrinsic Pontine Glioma – Drugs In Development, 2024
Empower your strategies with our Pediatric Diffuse Intrinsic Pontine Glioma – Drugs In Development, 2024 report and make more profitable business decisions. Pediatric diffuse intrinsic pontine glioma (DIPG) is a rare and aggressive type of brain tumor that primarily affects children, usually between the ages of five and 10 years. This tumor arises in the brainstem, specifically in the region known as the pons, which controls essential bodily functions such as breathing, heart rate, and muscle control. DIPG tumor location in...
-
Product Insights
NewMedulloblastoma – Drugs In Development, 2024
Empower your strategies with our Medulloblastoma – Drugs In Development, 2024 report and make more profitable business decisions. Medulloblastoma is the most common malignant brain tumor in children. Medulloblastoma by definition occurs in the cerebellum, which is the part of brain located at the base of the skull, just above the brainstem. Symptoms associated with a medulloblastoma include headaches in the morning that improve as the day goes on, recurrent vomiting, and difficulty with walking and balance. Medulloblastoma can spread to...
-
Product Insights
NewPontine Glioma – Drugs In Development, 2024
Empower your strategies with our Pontine Glioma – Drugs In Development, 2024 report and make more profitable business decisions. Pontine gliomas are highly aggressive and difficult to treat brain tumors found at the base of the brain. One of the most common types is diffuse intrinsic pontine glioma (DIPG). DIPG affects the pons portion of the brainstem, rendering nervous system function impossible. Symptoms include double vision, inability to close the eyelids completely, drooping of one side of the face, and difficulty...
-
Product Insights
NewNon Alcoholic Fatty Liver Disease (NAFLD) – Drugs In Development, 2024
Empower your strategies with our Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) – Drugs In Development, 2024 report and make more profitable business decisions. Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. Most people with NAFLD experience no signs and symptoms and no complications, but in some people with the disease, the fat that accumulates can cause inflammation and scarring in the liver. The most common symptoms that bring NAFLD to medical attention are...
-
Product Insights
NewBrain Cancer – Drugs In Development, 2024
Empower your strategies with our Brain Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Brain cancer refers to the abnormal growth of cells in the brain, forming tumors that can be benign (non-cancerous) or malignant (cancerous). Primary brain tumors originate in the brain itself, while secondary tumors result from the spread of cancer from other parts of the body. Symptoms may include headaches, seizures, changes in behavior, and cognitive impairment. Diagnosis involves imaging studies like MRI...
-
Product Insights
NewRecurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024
Empower your strategies with our Recurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024 report and make more profitable business decisions. Recurrent glioblastoma multiforme (GBM) refers to the return of aggressive brain tumors known as glioblastomas after initial treatment. GBM is the most malignant type of glioma, characterized by rapid growth and infiltrative behavior. Despite aggressive therapies like surgery, radiation, and chemotherapy, GBM often recurs due to its invasive nature and resistance to treatment. Management of recurrent GBM poses significant challenges....
-
Thematic Analysis
Low Cost Evolution Travel and Tourism – Thematic Intelligence
Low-Cost Evolution Travel and Tourism Thematic Report Overview Travel companies are targeting a wider range of customers as airfares and hotel tariffs have become affordable in recent years. The travel industry now encompasses every type of traveler, and this has resulted in the rising popularity of low-cost travel and tourism operators. Travel apps such as Airbnb and Uber have been at the forefront of the low-cost evolution. These apps shape travelers’ spending habits by sending push notifications regarding last-minute deals...